Covis Pharma is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. self-described as private equity backed.

Covis Pharma

VIRTRIS is a health data pioneer based in Seoul, South Korea, specializing in health data integration and analysis with the goal to accelerate drug discovery and approval.

VIRTRIS

Pharmaceutical Manufacturing

AMAG Pharmaceuticals | 19,541 followers on LinkedIn. At AMAG, aiming higher is in our DNA. We are a company driven to take on tough health challenges and find solutions for patients with complex, underserved conditions. 

Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicines across a range of therapeutic areas .

Award Winning Sales Director & Team Builder

Metric
Company Name	Covis Pharma	VIRTRIS
Symbol
MSH ID	COM:AMAGPHARMA	COM:VIRTRIS
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Biotechnology
Country	LU	KR
Stage
Employee Count
Website	amagpharma.com	virtris.com
LinkedIn	amag-pharmaceuticals	virtus
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AMAG

COM:AMAGPHARMA

Covis Pharma

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue